MDA-MB-468from AcceGen |
|
ABC-TC0657 | 1 vial: Ask for price | |
Description: The MDA-MB-468 cell line was isolated in 1977 by R. Cailleau, et al., From a pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast. |
|
MDA-MB-468from Creative Bioarray |
|
CSC-C9212W | One Frozen vial: Ask for price | |
Description: Breast Carcinoma Cells |
|
MDA-MB-468 cellsfrom Addexbio |
|
C0006003 | One Frozen vial: 390.00 EUR | |
MDA-MB-468 Cell Linefrom Elabscience Biotech |
|
CL-0290 | 1×10⁶ cells/vial: 420.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-468 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0290A | 125mL×4: 98.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-468 FFPE Cell Pellet Blockfrom Creative Bioarray |
|
BreFFPE-CP007 | 1 Block: Ask for price | |
Description: Breast |
|
MDA-MB-468 FFPE Cell Pellet Slidesfrom Creative Bioarray |
|
BreFFPE-CP008 | 5 Slides: Ask for price | |
Description: Breast |
|
MDA-MB-468 FFPE Cell Pellet Scrollsfrom Creative Bioarray |
|
BreFFPE-CP009 | 5 Scrolls: Ask for price | |
Description: Breast |
|
GFP-Human MDA-MB-435(MDA-MB-435)from AcceGen |
|
ABC-RC211D | 1 vial: Ask for price | |
Description: Human MDA-MB-435 is a cell line isolated from the pleural effusion of a 31 year old female with metastatic, ductal adenocarcinoma of the breast. GFP-expressing MDA-MB-435 (GFP-MDA-MB-435) are selected from MDA-MB-435 cells after infected with lentiviruses expressing GFP with puromycin. The cells are shipped in a frozen vial with more than 5 x 105 cells/vial. Universal Full Growth Medium is recommended for cell culture and these cells have an average minimum population doubling levels > 20 when cultured following the detailed protocol described below. |
|
MDA-MB-157from AcceGen |
|
ABC-TC0649 | 1 vial: Ask for price | |
Description: The cells express the WNT7B oncogene. Desmosomes, microvilli and tonofilaments were observed at boundaries between cells. |
|
MDA-MB-231from AcceGen |
|
ABC-TC0651 | 1 vial: Ask for price | |
Description: Species: human, Caucasian female 51 years old; Tissue: breast; Tumor: adenocarcinoma; Derived from: pleural effusion. |
|
MDA-MB-361from AcceGen |
|
ABC-TC0652 | 1 vial: Ask for price | |
Description: This line differs from others of the series in karyology and in that it was isolated from a brain metastasis. |
|
MDA-MB-415from AcceGen |
|
ABC-TC0653 | 1 vial: Ask for price | |
Description: The cells express the WNT7B oncogene. The patient presenting with the tumor was from Paraguay and, although listed as Caucasian, may have had mixed ancestry as suggested by the presence of G6PD type A phenotype in the cells. |
|
MDA-MB-436from AcceGen |
|
ABC-TC0655 | 1 vial: Ask for price | |
Description: The line is pleomorphic and most cells react intensely with anti tubulin antibody as demonstrated by indirect immunofluorescence staining. |
|
MDA-MB-453from AcceGen |
|
ABC-TC0656 | 1 vial: Ask for price | |
Description: MDA-MB-453 was derived in 1976 by R. Cailleau et al. From an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities.The cells overexpress FGF receptors. |
|
MDA-MB-436from Addexbio |
|
C0006032 | One Frozen vial: 390.00 EUR | |
MDA-MB-361from Addexbio |
|
C0006051 | One Frozen vial: 500.00 EUR | |
MDA-MB-231from Creative Bioarray |
|
CSC-C8210L | One Frozen vial: Ask for price | |
Description: Breast Carcinoma Cells |
|
MDA-MB-436from Creative Bioarray |
|
CSC-C8864H | One Frozen vial: Ask for price | |
Description: Breast Carcinoma Cells |
|
MDA-MB-361from Creative Bioarray |
|
CSC-C9211W | One Frozen vial: Ask for price | |
Description: Breast Carcinoma Cells |
|
MDA-MB-453from Creative Bioarray |
|
CSC-C9488L | One Frozen vial: Ask for price | |
Description: Breast Carcinoma Cells |
|
MDA-MB-231from MyBiosource |
|
MBS201050-01mg | 0.1mg: 215.00 EUR | |
MDA-MB-231from MyBiosource |
|
MBS201050-02mg | 0.2mg: 230.00 EUR | |
MDA-MB-231from MyBiosource |
|
MBS201050-05mg | 0.5mg: 300.00 EUR | |
MDA-MB-231from MyBiosource |
|
MBS201050-5x05mg | 5x0.5mg: 1115.00 EUR | |
MDA-MB-435Sfrom AcceGen |
|
ABC-TC0654 | 1 vial: Ask for price | |
Description: MDA-MB-435S is a spindle shaped strain which evolved from the parent line (435) isolated in 1976 (R. Cailleau et al.) From the pleural effusion of a 31 year old female with metastatic ductal adenocarcinoma of the breast. |
|
MDA-MB-134-VIfrom AcceGen |
|
ABC-TC0648 | 1 vial: Ask for price | |
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells. |
|
MDA-MB-175-VIIfrom AcceGen |
|
ABC-TC0650 | 1 vial: Ask for price | |
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells. |
|
MDA-MB-231 cellsfrom Addexbio |
|
C0006002 | One Frozen vial: 390.00 EUR | |
MDA-MB-157 cellsfrom Addexbio |
|
C0006020 | One Frozen vial: 390.00 EUR | |
Human MDA-MB-435from Angio Proteomie |
|
cAP-0049 | 1Frozen Vial: 396.00 EUR | |
MDA-MB-361 Lysatefrom MyBiosource |
|
MBS151590-01mg | 0.1mg: 200.00 EUR | |
MDA-MB-361 Lysatefrom MyBiosource |
|
MBS151590-5x01mg | 5x0.1mg: 880.00 EUR | |
MDA-MB-175VII cellsfrom Addexbio |
|
C0006009 | One Frozen vial: 390.00 EUR | |
MDA-MB-231 Cell Linefrom Elabscience Biotech |
|
CL-0150 | 1×10⁶ cells/vial: 420.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-453 Cell Linefrom Elabscience Biotech |
|
CL-0152 | 1×10⁶ cells/vial: 420.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-415 Cell Linefrom Elabscience Biotech |
|
CL-0382 | 1×10⁶ cells/vial: 500.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-436 Cell Linefrom Elabscience Biotech |
|
CL-0383 | 1×10⁶ cells/vial: 500.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-361 Cell Linefrom Elabscience Biotech |
|
CL-0553 | 1×10⁶ cells/vial: 500.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-175VII Cell Linefrom Elabscience Biotech |
|
CL-0381 | 1×10⁶ cells/vial: 500.00 EUR | |
Description: Homo sapiens, Human |
|
MDA-MB-435s Cell Lysatefrom MyBiosource |
|
MBS3248720-02mg | 0.2mg: 160.00 EUR | |
MDA-MB-435s Cell Lysatefrom MyBiosource |
|
MBS3248720-5x02mg | 5x0.2mg: 625.00 EUR | |
Human MDA-MB-361 Cell Lysatefrom Innovative research |
|
IHUMDAMB361TL100UG | each: 245.00 EUR | |
Description: Human MDA-MB-361 Cell Lysate |
|
Human MDA-MB-361 Cell Lysatefrom MyBiosource |
|
MBS8415073-01mg | 0.1mg: 385.00 EUR | |
Human MDA-MB-361 Cell Lysatefrom MyBiosource |
|
MBS8415073-5x01mg | 5x0.1mg: 1540.00 EUR | |
GFP Expressing Human MDA-MB-435from Angio Proteomie |
|
cAP-0049GFP | 1Frozen Vial: 782.10 EUR | |
GFP Expressing Human MDA-MB-435from Alphabioregen |
|
ALHC006-GFP | 1ml frozen Vial: 0.20 EUR | |
MDA-MB-231 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0150A | 125mL×4: 98.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-453 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0152A | 125mL×4: 98.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-415 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0382A | 125mL×4: 128.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-436 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0383A | 125mL×4: 128.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-361 Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0553A | 125mL×4: 128.00 EUR | |
Description: Cell lines complete growth medium |
|
OCPB00165-100UG - MDA-MB-361 Lysatefrom Aviva Systems Biology |
|
OCPB00165-100UG | 0.1mg: 139.00 EUR | |
MDA-MB-175VII Cells Complete Mediumfrom Elabscience Biotech |
|
CM-0381A | 125mL×4: 98.00 EUR | |
Description: Cell lines complete growth medium |
|
MDA-MB-231 / TetR (Puro) stable cellsfrom GenTarget |
|
SC040-TetR | 2 x 106 cell/ml x 1ml: 1452.00 EUR | |
Description: Tetracycline repressor expression stable cell line with Puromycin marker in MDA-MB-231 human breast cancer cells. |
|
MDA-MB-453 FFPE Cell Pellet Blockfrom Creative Bioarray |
|
BreFFPE-CP001 | 1 Block: Ask for price | |
Description: Breast |
|
MDA-MB-231 FFPE Cell Pellet Blockfrom Creative Bioarray |
|
BreFFPE-CP004 | 1 Block: Ask for price | |
Description: Breast |
|
MDA-MB-453 FFPE Cell Pellet Slidesfrom Creative Bioarray |
|
BreFFPE-CP002 | 5 Slides: Ask for price | |
Description: Breast |
|
MDA-MB-231 FFPE Cell Pellet Slidesfrom Creative Bioarray |
|
BreFFPE-CP005 | 5 Slides: Ask for price | |
Description: Breast |
|
Human MDA-MB-435S Whole Cell Lysatefrom Innovative research |
|
IHUMDAMB435STLW500UG | each: 327.00 EUR | |
Description: Human MDA-MB-435S Whole Cell Lysate |
|
MDA-MB-453 FFPE Cell Pellet Scrollsfrom Creative Bioarray |
|
BreFFPE-CP003 | 5 Scrolls: Ask for price | |
Description: Breast |
|
MDA-MB-231 FFPE Cell Pellet Scrollsfrom Creative Bioarray |
|
BreFFPE-CP006 | 5 Scrolls: Ask for price | |
Description: Breast |
|
Human MDA-MB-435S Whole Cell Lysatefrom MyBiosource |
|
MBS8415075-05mg | 0.5mg: 505.00 EUR | |
Human MDA-MB-435S Whole Cell Lysatefrom MyBiosource |
|
MBS8415075-5x05mg | 5x0.5mg: 2050.00 EUR | |
Human MDA-MB-231 Breast Cancer Cellsfrom Angio Proteomie |
|
cAP-0034 | 1Frozen Vial: 396.00 EUR | |
Cas9-Expressing MDA-MB-231 cell poolfrom BPS Bioscience |
|
78069 | 2 million cells: 795.00 EUR | |
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing MDA-MB-231 cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines. |
|
Human MDA-MB-435S Cell Lysate Lyophilizedfrom Innovative research |
|
IHUMDAMB435STLLY200UG | each: 89.00 EUR | |
Description: Human MDA-MB-435S Cell Lysate Lyophilized |
|
Human MDA-MB-435S Cell Lysate Lyophilizedfrom MyBiosource |
|
MBS8415074-02mg | 0.2mg: 205.00 EUR | |
Human MDA-MB-435S Cell Lysate Lyophilizedfrom MyBiosource |
|
MBS8415074-5x02mg | 5x0.2mg: 745.00 EUR | |
Human MDA-MB-361 (Breast Adenocarcinoma) lysatefrom Alpha Diagnostics |
|
HCL-1217 | 100ug: 285.60 EUR | |
MDA-MB-231 / GFP (Bsd) Stable Cell Linefrom GenTarget |
|
SC040-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR | |
Description: GFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|
MDA-MB-231 / RFP (Bsd) Stable Cell Linefrom GenTarget |
|
SC057-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR | |
Description: RFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|
MDA-MB-231 / GFP (Puro) Stable Cell Linefrom GenTarget |
|
SC040-Puro | 2 x 106 cell/ml x 1ml: 1452.00 EUR | |
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|
GFP-Human MDA-MB-231 Breast Cancer Cellsfrom AcceGen |
|
ABC-RC207D | 1 vial: Ask for price | |
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. GFP-MDA-MB-231 cells are selected from puromycin resistant MDA-MB-231 after infected with GFP Expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial. |
|
RFP-Human MDA-MB-231 Breast Cancer Cellsfrom AcceGen |
|
ABC-RC208D | 1 vial: Ask for price | |
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. RFP-MDA-MB-231 cells are selected from Zeocin resistant MDA-MB-231 cells after infected with RFP expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial. |
|
MDA-MB-231 / Luciferase (Bsd) Stable Cell Linefrom GenTarget |
|
SC059-Bsd | 2 x 106 cell/ml x 1ml: 1800.00 EUR | |
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|
MDA-MB-231 / Luciferase (Puro) Stable Cell Linefrom GenTarget |
|
SC059-Puro | 2 x 106 cell/ml x 1ml: 1800.00 EUR | |
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance |
|
OCRA00105-500UG - MDA-MB-435S Whole Cell Lysatefrom Aviva Systems Biology |
|
OCRA00105-500UG | 500ug: 189.00 EUR | |
MDA-MB-231 / Luciferase-2A-RFP Stable Cell Linefrom GenTarget |
|
SC041 | 2 x 106 cell/ml x 1ml: 2670.00 EUR | |
Description: Firefly luciferase and GFP co-expression stable cell line in MDA-MB-231 cells with Blasticidin resistance |
|
MDA-MB-231 / Luciferase-2A-GFP Stable Cell Linefrom GenTarget |
|
SC044 | 2 x 106 cell/ml x 1ml: 2670.00 EUR | |
Description: Luciferase (firefry) and GFP co-expression stable cell line in MDA-MB-231 human breast cancer cell line with Puromycin marker. |
|
Human NFkB Luciferase Reporter Cell Line- MDA-MB-231from AcceGen |
|
ABC-RC0026 | 1 vial: Ask for price | |
Description: Human NFkB Luciferase Reporter Cell Line- MDA-MB-231 is derived from Human breast cancer, and stably express firefly luciferase reporter gene under the control of NFkB response element. This cell line is an ideal cellular model for monitoring the activation of NFkB response Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown. |
|
GFP Expressing Human MDA-MB-231 Breast Cancer Cellsfrom Angio Proteomie |
|
cAP-0034GFP | 1Frozen Vial: 782.10 EUR | |
RFP Expressing Human MDA-MB-231 Breast Cancer Cellsfrom Angio Proteomie |
|
cAP-0034RFP | 1Frozen Vial: 782.10 EUR | |
GFP Expressing Human MDA-MB-231 Breast Cancer Cellsfrom Alphabioregen |
|
ALHC001-GFP | 1ml frozen Vial: 0.20 EUR | |
RFP Expressing Human MDA-MB-231 Breast Cancer Cellsfrom Alphabioregen |
|
ALHC002-RFP | 1ml frozen Vial: 0.20 EUR | |
MDA-19from Abbexa |
|
abx282212-100g | 100 µg: Ask for price | |
MDA-19from Abbexa |
|
abx282212-20g | 20 µg: 175.00 EUR | |
MDA-19from Abbexa |
|
abx282212-50g | 50 µg: 512.50 EUR |